Literature DB >> 16126924

Deep venous thrombosis: withholding anticoagulation therapy after negative complete lower limb US findings.

Rathan M Subramaniam1, Rebekah Heath, Tina Chou, Kim Cox, Gavin Davis, Michael Swarbrick.   

Abstract

PURPOSE: To establish the safety of withholding anticoagulation therapy after negative findings at a complete lower limb ultrasonographic (US) examination of the symptomatic leg for suspected deep venous thrombosis (DVT).
MATERIALS AND METHODS: Regional ethics committee approval and patient consent were obtained. A total of 542 consecutive ambulatory patients presented to the emergency department and were prospectively recruited from April 2001 to May 2003. Of these patients, 16 were excluded, and radiology residents and sonographers performed a complete lower limb US examination by means of compression and Doppler US in 526 patients. Patients with negative US findings received no anticoagulation therapy, and they were observed for occurrence of any thromboembolic event for 3 months. Patients with progressive or new symptoms that were indicative of thromboembolism within the follow-up period underwent objective testing with US, computed tomographic (CT) pulmonary angiography, or both.
RESULTS: There were 413 patients (78.5%) with US findings that were negative for DVT and 113 patients (21.5%) with findings that were positive. There were 64 patients (56.6%) with DVT isolated to the calf and 49 (43.4%) with proximal DVT. Of the 413 patients with negative initial US findings, 16 (3.9%) underwent a second US examination for new or progressive symptoms of DVT, one patient (0.25%) underwent CT pulmonary angiography for suspected pulmonary embolism, and one patient (0.25%) underwent both US and CT pulmonary angiography during the 3-month follow-up period. One of these patients (0.24%; 95% confidence interval: 0.01%, 1.3%) developed pulmonary embolism, which was diagnosed with CT pulmonary angiography. DVT was not diagnosed in any patient, and no patient died during follow-up. The negative predictive value of a complete single lower limb US examination to exclude clinically important DVT is 99.6% (95% confidence interval: 98.4%, 99.9%).
CONCLUSION: A single negative complete lower limb US examination is sufficient to exclude clinically important DVT, and it is safe to withhold anticoagulation therapy after negative complete lower limb US findings were obtained in patients suspected of having symptomatic lower limb DVT. New or progressive symptoms require further objective imaging. RSNA, 2005

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126924     DOI: 10.1148/radiol.2371041294

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Roman Jaeschke; Scott M Stevens; Steven Goodacre; Philip S Wells; Matthew D Stevenson; Clive Kearon; Holger J Schunemann; Mark Crowther; Stephen G Pauker; Regina Makdissi; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Risk of Venous Thromboembolism after a Single Normal Proximal Lower Extremity Venous Ultrasound.

Authors:  Myles M Mitsunaga; Shannon Kogachi; Hyo-Chun Yoon
Journal:  Perm J       Date:  2017

3.  3D T(1)-mapping for the characterization of deep vein thrombosis.

Authors:  Ulrike Blume; James Orbell; Matthew Waltham; Alberto Smith; Reza Razavi; Tobias Schaeffter
Journal:  MAGMA       Date:  2009-11-28       Impact factor: 2.310

Review 4.  Should we diagnose and treat distal deep vein thrombosis?

Authors:  Helia Robert-Ebadi; Marc Righini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Joint Guideline on Venous Thromboembolism - 2022.

Authors:  Ana Cristina Lopes Albricker; Cláudia Maria Vilas Freire; Simone Nascimento Dos Santos; Monica Luiza de Alcantara; Mohamed Hassan Saleh; Armando Luis Cantisano; José Aldo Ribeiro Teodoro; Carmen Lucia Lascasas Porto; Salomon Israel do Amaral; Orlando Carlos Gloria Veloso; Ana Cláudia Gomes Pereira Petisco; Fanilda Souto Barros; Márcio Vinícius Lins de Barros; Adriano José de Souza; Marcone Lima Sobreira; Robson Barbosa de Miranda; Domingos de Moraes; Carlos Gustavo Yuji Verrastro; Alexandre Dias Mançano; Ronaldo de Souza Leão Lima; Valdair Francisco Muglia; Cristina Sebastião Matushita; Rafael Willain Lopes; Artur Martins Novaes Coutinho; Diego Bromfman Pianta; Alair Augusto Sarmet Moreira Damas Dos Santos; Bruno de Lima Naves; Marcelo Luiz Campos Vieira; Carlos Eduardo Rochitte
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

6.  Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study.

Authors:  Murray M Bern; Diane Hazel; Elizabeth Deeran; John R Richmond; Daniel M Ward; Damon J Spitz; David A Mattingly; James V Bono; Ronna H Berezin; Laura Hou; Gerald B Miley; Benjamin E Bierbaum
Journal:  Thromb J       Date:  2015-10-07

7.  Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis.

Authors:  Noémie Kraaijpoel; Marc Carrier; Grégoire Le Gal; Matthew D F McInnes; Jean-Paul Salameh; Trevor A McGrath; Nick van Es; David Moher; Harry R Büller; Patrick M Bossuyt; Mariska M G Leeflang
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.